Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Holiday Inn Bloomsbury

Apr 17, 2013 8:00 AM - Apr 18, 2013 5:00 PM

Coram Street, London, WC1N 1HT, United Kingdom

7th European Forum for Qualified Person for Pharmacovigilance (QPPV) 17-18 April 2013; Pre-conference Workshop 16 April 2013

Reflections on the New Legislation; is it meeting the objectives?

Session Chair(s)

Michael  Richardson, MD, FFPM, FRCP

Michael Richardson, MD, FFPM, FRCP

Senior Vice President, WorldWide Patient Safety

Bristol-Myers Squibb, United Kingdom

Speaker(s)

Thomas  Lönngren, PharmD

Are Patients Better Protected? – An industry view

Thomas Lönngren, PharmD

NDA Group, Sweden

Strategic Advisor

Barry  Arnold, MD

Was the Pain Worth the Gain?

Barry Arnold, MD

AstraZeneca, United Kingdom

EU Qualified Person for Pharmacovigilance

David  Haerry

And what do patients think?

David Haerry

EUPATI Foundation,European AIDS Treatment Group, Belgium

Co-Chair Advisory Committee

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.